Description: Presented at October 1985 Annual Meeting. Discusses risk measurement and quantification, cash-flow-based surplus, factors that affect benchmark surplus, how multiple risks can be combined for benchmark surplus, benchmark surplus and the valuation actuary, and uses of benchmark surplus formulas.

Description: The presenters describe the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. Learn the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. Walk through sample models that illustrate how costs for emerging technologies and treatments can be modeled.

Description: This session is about the methods of projecting long-run stock returns using inflation rates from bond yield curves with incremental returns for risk taking based on historical data and the relationship between concurrent, expected and unexpected inflation rates and the rates of return on common stocks and U.S. government bonds and notes. From Record of Society of Actuaries Vol. 5, No. 4.

Description: Presented at May 2002 Spring Meeting. Discusses the status of the second phase of the AAA C-3 Risk project. This project is leading to an updated NAIC filing requirement and is a step toward fair value. The specific focus is on equity risk and bond funds in the distribution tails. Products covered include variable life and annuities.

Description: Presented at May 2002 Spring Meeting. Attendees learn about the new capital allocation, the financial products company 'FPC' model recently developed by S&P -including S&P's view of interest rate risk and credit risk in the FPC model, challenges of implementing the model for a life insurance company, and how the FPC model compares to economic capital methodology.

Description: Risk management techniques such as stress testing and setting capital targets are fairly well established for life insurers; however, the implementation of these techniques can vary considerably. A fundamental question is how to manage multiple valuation perspectives, and the list of possibilities keeps growing. Companies can potentially consider some or all of the following: U.S. reporting measures (Stat, GAAP), internal measures (EV, VNB, economic capital), international reporting measures (IFRS), rating agency models or other developing standards (ICS, NAIC group capital). This session will begin with a quick overview of the defining characteristics of different valuation frameworks. We will then provide more focused and practical considerations for managing risk and capital under different frameworks, using specific examples to highlight key trade offs.

Description: The Society's Task Force to Study Risk of Loss from Changes in the Interest Rate Environment C-3 Risk Task Force was formed in March 1981 with the charge to quantify C-3 risk. The Task Force made a preliminary report as part of a panel discussion on C-3 risk at the Society's October 1981 meeting in Atlanta. This presentation provides an update on the progress to date and its future plans.

Description: Presented at May 1986 Spring Meeting. This session discussion is about how much surplus is needed, how it is determined, treatment of participating policyholders, approaches for measurement, and regulatory and professional body requirements affecting surplus relief reinsurance.

Description: Presented at October 1996 Annual Meeting. This session presents and discusses the NAIC's model bill for risk-based capital as it relates to health insurance.

Description: Presented at May 2005 Spring Meeting. Panelists discuss annuity risk management, with particular focus on RBC and the proposed Actuarial Guideline on reserving, and how this can be applied to new product development as well as in-force product management.